根据数据统计,截至11月19日,A股和港股的千亿市值创新药企俱乐部已扩容至8家。其中,百济神州A股总市值超过4000亿元,百利天恒总市值超过1500亿元。港股千亿市值俱乐部包括百济神州、翰森制药、信达生物、康方生物等。其中,总市值超4000亿元的创新药企业百济神州已连续两个季度实现盈利。根据公司财务数据显示,今年前三季度,百济神州营收同比增长44.2%,达275.95亿元,已超过2024年全年。...
Source Link根据数据统计,截至11月19日,A股和港股的千亿市值创新药企俱乐部已扩容至8家。其中,百济神州A股总市值超过4000亿元,百利天恒总市值超过1500亿元。港股千亿市值俱乐部包括百济神州、翰森制药、信达生物、康方生物等。其中,总市值超4000亿元的创新药企业百济神州已连续两个季度实现盈利。根据公司财务数据显示,今年前三季度,百济神州营收同比增长44.2%,达275.95亿元,已超过2024年全年。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.